COWZ vs XBI
Pacer US Cash Cows 100 ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.49% for COWZ.
- • COWZ pays a higher dividend yield (1.99%).
Side-by-side metrics
| Metric | COWZ | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.49% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.99% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $17.59B | $10.73B |
YTD return | 6.25% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.65 | 1.10 |
P/E ratio | 16.29 | — |
Last price | $63.82 | $164.01 |
Inception | — | — |
Issuer | Pacer | State Street |
COWZ top holdings
| BKNG | Booking Holdings Inc | 2.21% |
| HCA | HCA Healthcare Inc | 2.15% |
| LOW | Lowe's Companies Inc | 2.15% |
| CMCSA | Comcast Corp Class A | 2.12% |
| UBER | Uber Technologies Inc | 2.10% |
| BMY | Bristol-Myers Squibb Co | 2.07% |
| MO | Altria Group Inc | 2.05% |
| GD | General Dynamics Corp | 2.04% |
| GILD | Gilead Sciences Inc | 2.01% |
| TMUS | T-Mobile US Inc | 1.93% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About COWZ
COWZ (Pacer US Cash Cows 100 ETF) is 100 Russell 1000 stocks with highest free cash flow yield. Managed by Pacer, the fund carries $17.6B in assets under management, an expense ratio of 0.49%, a dividend yield of 1.99%. Its largest holding is Booking Holdings Inc (BKNG), which represents 2.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 14.3%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.